Fragments 2015: Fifth RSC-BMCS Fragment-based Drug Discovery meeting

22 - 24 March 2015, Cambridge, United Kingdom

The aim of the 5th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with the theme, having over three-quarters of the presentations focussed on case studies. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.
  • Alessio Ciulli University of Dundee, United Kingdom
  • Frank Böckler University of Tübingen, Germany
  • Jonathan Mason Heptares, United Kingdom
  • Paul Brennan SGC, United Kingdom
  • Stephen Pickett GlaxoSmithKline, United Kingdom
  • Rich Taylor UCB, United Kingdom
  • Gavin Hirst Takeda, United States
  • Joe Patel AstraZeneca, United States
  • David Rees Astex Therapeutics, United Kingdom

Sponsorship & supporting organisations
Sponsors for this well-established event are welcomed.
Churchill College

Wolfson Theatre, Churchill College, Storey's Way, Cambridge, CB3 0DS, United Kingdom

Organised by
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry